Better monitoring of cancer immunotherapy patients

Start typing and press Enter to search

  • Home
  • Project
  • Consortium
  • Results
  • News
  • Events
  • Contact
Better monitoring of cancer immunotherapy patients

Start typing and press Enter to search

  • Home
  • Project
  • Consortium
  • Results
  • News
  • Events
  • Contact
Better monitoring of cancer immunotherapy patients

Start typing and press Enter to search

  • Home
  • Project
  • Consortium
  • Results
  • News
  • Events
  • Contact
  • Facebook
  • Twitter

Uncategorized

0
By admin
In Uncategorized
Posted August 30, 2024

Previous Events

Amsterdam Barcelona Brussels Lisbon London Lyon

READ MORE
QUALITOP Conference: Results of the Project and Patients’ Perspective
0
By admin
In Uncategorized
Posted August 16, 2024

QUALITOP Conference: Results of the Project and Patients’ Perspective

On the 26th of June, QUALITOP organised a public conference in Amsterdam, concentrating on the challenges and advancements in clinical trials and quality of life research, particularly [...]

READ MORE
0
By admin
In Uncategorized
Posted August 13, 2024

The QUALITOP workshop: Sustainability and Continuity

On Wednesday, 26th June 2024, Amsterdam hosted a workshop on the QUALITOP project, a groundbreaking effort to improve cancer patients’ quality of life through digital technologies. This [...]

READ MORE
0
By admin
In Uncategorized
Posted June 25, 2024

QUALITOP NEWSLETTER ISSUE 4

On Tuesday, 25th of June, we published the fourth newsletter from QUALITOP. An overview of the latest updates on the project and updates on upcoming events. Please click here to read the […]

READ MORE
0
By admin
In Uncategorized
Posted May 17, 2024

Publication: New Promising Results from the Dutch CAR-T Tumorboard Experience.

Chimeric antigen receptor T-cell therapy, also known as CAR T-cell therapy, is a form of immunotherapy utilised in the treatment of cancer. For this therapy, a technique involves altering T […]

READ MORE

Copyright © 2020 QUALITOP    This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 875171.

Start typing and press Enter to search